Cargando…
The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
BACKGROUND: Pre-exposure prophylaxis (PrEP) with daily oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prevents HIV infection. The safety and feasibility of HIV PrEP in the setting of hepatitis B virus (HBV) infection were evaluated. METHODS: The Iniciativa Profilaxis Pre-Exposición s...
Autores principales: | Solomon, Marc M., Schechter, Mauro, Liu, Albert Y., McManhan, Vanessa M., Guanira, Juan V., Hance, Robert J., Chariyalertsak, Suwat, Mayer, Kenneth H., Grant, Robert M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752387/ https://www.ncbi.nlm.nih.gov/pubmed/26413853 http://dx.doi.org/10.1097/QAI.0000000000000857 |
Ejemplares similares
-
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
por: Solomon, Marc M., et al.
Publicado: (2014) -
Daily HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate-emtricitabine reduced Streptococcus and increased Erysipelotrichaceae in rectal microbiota
por: Dubé, Michael P., et al.
Publicado: (2018) -
PrEP stigma among current and non-current PrEP users in Thailand: A comparison between hospital and key population-led health service settings
por: Chautrakarn, Sineenart, et al.
Publicado: (2022) -
Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study
por: Amico, K. Rivet, et al.
Publicado: (2016) -
1285. PrEP Acceptability, Uptake, and Adherence Among Young Men Who Have Sex with Men and Transgender Women in PrEP Demonstration Project, Chiang Mai, Thailand
por: Kaewpoowat, Quanhathai, et al.
Publicado: (2019)